Discov Oncol

期刊全称Discov Oncol
注：上述信息均来源于网络，仅供查考，如有遗漏或信息错误，欢迎 向我反馈。

期刊相关文献 (34)

Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications

血浆蛋白水平与肝细胞癌：一项具有药物筛选意义的孟德尔随机化研究

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-02307-7
Longhui Xie # ，Dekun Song # ，Jianwei Lan # ，Pengpeng Liu ，Shuang Qin ，Yinkuan Ning ，Quanyan Liu
发表日期：2025
全文求助 收藏

Analysis of microarray and single-cell RNA-seq identifies gene co-expression, cell-cell communication, and tumor environment associated with metabolite interconversion enzyme in prostate cancer

微阵列和单细胞RNA测序分析揭示了前列腺癌中代谢物相互转化酶相关的基因共表达、细胞间通讯和肿瘤微环境。

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-01926-4.
Danial Hashemi Karoii # ,Ali Shakeri Abroudi # ,Nadia Forghani # ,Sobhan Bavandi ,Melika Djamali ,Hamoon Baghaei ,Sana Shafaeitilaki ,Ehsan HasanZadeh
发表日期：2025
全文求助 收藏

Single-cell profiling of ERBB family receptors identifies ERBB3 as a key regulator in head and neck squamous cell carcinoma progression

单细胞分析ERBB家族受体发现ERBB3是头颈部鳞状细胞癌进展的关键调控因子

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-03681-y
Yuling Luo # ，Youwei Li # ，Shuqin Liu ，Renmei Hu ，Jinzhi Wu
发表日期：2025
全文求助 收藏

Identification of potential oncogenic miRNA clusters with a special focus on miR-106b/25 cluster-regulated networks and their clinical utility in hepatocellular carcinoma

鉴定潜在的致癌性miRNA簇，重点关注miR-106b/25簇调控网络及其在肝细胞癌中的临床应用

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-03834-z.
Shreyas Hulusemane Karunakara ,Manju Moorthy ,Gopalakrishna Ramaswamy ,Vinutha Shanubhoganahalli Puttamallapa ,Maheshkumari Prakash ,Rohit Mehtani ,Shama Prasada Kabekkodu ,Prashant M Vishwanath ,Prasanna Kumar Santhekadur
发表日期：2025
全文求助 收藏

Fedratinib inhibits ovarian cancer progression by downregulating QPCT expression

Fedratinib通过下调QPCT表达抑制卵巢癌进展

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-03734-2.
Ying Dong ,Yue Deng ,Longyan Zhu ,Rongji Li ,Huilin Yang ,Lihua Yang
发表日期：2025
全文求助 收藏

A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7

A-to-I RNA 编辑的 POLA2 通过抑制免疫浸润和上调 BTBD7 促进前列腺癌的发生。

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-02449-8
Shengyi Lin ，Hang Huang ，Yeping Li ，Yongyong Lu ，Tingyu Ye
发表日期：2025
全文求助 收藏

Regulation of iodide transportation by a plant secondary metabolite in SW1736 anaplastic thyroid cancer cell line

植物次生代谢产物对SW1736间变性甲状腺癌细胞系中碘化物运输的调控

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-02339-z
Shabnam Heydarzadeh ，Ali Asghar Moshtaghie ，Maryam Daneshpour ，Mehdi Hedayati
发表日期：2025
全文求助 收藏

Integrative bulk RNA analysis unveils immune evasion mechanisms and predictive biomarkers of osimertinib resistance in non-small cell lung cancer

整合式批量RNA分析揭示非小细胞肺癌中免疫逃逸机制和奥希替尼耐药的预测性生物标志物

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-02529-9
Ling Shi ,Feng Qiu ,Chao Shi ,Guohua Zhang ,Feng Yu
发表日期：2025
全文求助 收藏

TIGAR inhibits glucose-metabolism and cisplatin-chemosensitivity in human lung cancer cells

TIGAR抑制人肺癌细胞的葡萄糖代谢和顺铂化疗敏感性

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-03274-9
Yang Feng # ,Yiling Meng # ,Meichao Zhang # ,Yingxia Ying ,Yuan Yao ,Dong Li
发表日期：2025
全文求助 收藏

The role of UBR2 in triple-negative breast cancer and its implications for immune checkpoint blockade therapy

UBR2在三阴性乳腺癌中的作用及其对免疫检查点阻断疗法的意义

期刊:Discov Oncol
影响因子:2.800
doi:10.1007/s12672-025-03153-3
Yanlin Jiang # ，Yi Fu # ，Xinyan Song ，Yongjie Xie ，Xiaobin Shang ，Xi Liang
发表日期：2025
全文求助 收藏
  • 1
  • 2
  • 3
  • 4